Twin Capital Management Inc. Acquires 16,288 Shares of Corteva, Inc. $CTVA

Twin Capital Management Inc. lifted its holdings in Corteva, Inc. (NYSE:CTVA) by 178.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 25,394 shares of the company’s stock after buying an additional 16,288 shares during the period. Twin Capital Management Inc.’s holdings in Corteva were worth $1,702,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Activest Wealth Management increased its holdings in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares during the last quarter. JPL Wealth Management LLC bought a new stake in shares of Corteva in the 3rd quarter worth about $25,000. Redmont Wealth Advisors LLC bought a new stake in shares of Corteva in the 3rd quarter worth about $29,000. Jackson Grant Investment Advisers Inc. increased its holdings in shares of Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after buying an additional 213 shares during the last quarter. Finally, KERR FINANCIAL PLANNING Corp bought a new stake in shares of Corteva in the 3rd quarter worth about $33,000. 81.54% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.15% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on CTVA shares. Wells Fargo & Company lifted their price target on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 21st. Mizuho lifted their price target on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Wolfe Research lifted their price target on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. UBS Group lifted their price target on shares of Corteva from $88.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Finally, Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Thirteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.14.

Corteva Price Performance

Corteva stock opened at $78.77 on Thursday. The stock has a market cap of $52.68 billion, a price-to-earnings ratio of 46.33, a price-to-earnings-growth ratio of 2.42 and a beta of 0.59. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The firm has a 50-day moving average of $81.25 and a two-hundred day moving average of $73.79.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the previous year, the company earned $1.13 EPS. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.